 reducing overall ischemic events.131 However,
analysis of a subset of patients with a prior history of
stroke in the CAPRIE trial demonstrated no difference
in incidence of vascular events.131 In the European/Australasian Stroke Prevention in Reversible Ischemia Trial,
patients were randomized to aspirin or aspirin Ã¾
extended release dipyridamole therapy within 6 months
of a TIA or stroke. The study showed a statistically significant lower rate of